SIGA’s antiviral approved in Japan for orthopoxvirus treatment
SIGA Technologies has gained Japanese regulatory approval for TEPOXX (tecovirimat) 200mg capsules, known as TPOXX in the US, ...
Pharmaceutical Technology17 天
Azercabtagene zapreleucel by Imugene for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
Azercabtagene zapreleucel is under clinical development by Imugene and currently in Phase I for Diffuse Large B-Cell Lymphoma. According to GlobalData, Phase I drugs for Diffuse Large B-Cell Lymphoma ...